Use	0	3	O
of	4	6	O
uteroglobin	7	18	B-Gene_or_gene_product
for	19	22	O
the	23	26	O
engineering	27	38	O
of	39	41	O
polyvalent	42	52	O
,	52	53	O
polyspecific	54	66	O
fusion	67	73	O
proteins	74	82	O
.	82	83	O

We	85	87	O
report	88	94	O
a	95	96	O
novel	97	102	O
strategy	103	111	O
to	112	114	O
engineer	115	123	O
and	124	127	O
express	128	135	O
stable	136	142	O
and	143	146	O
soluble	147	154	O
human	155	160	B-Organism
recombinant	161	172	O
polyvalent	173	183	O
/	183	184	O
polyspecific	184	196	O
fusion	197	203	O
proteins	204	212	O
.	212	213	O

The	214	217	O
procedure	218	227	O
is	228	230	O
based	231	236	O
on	237	239	O
the	240	243	O
use	244	247	O
of	248	250	O
a	251	252	O
central	253	260	O
skeleton	261	269	O
of	270	272	O
uteroglobin	273	284	B-Gene_or_gene_product
,	284	285	O
a	286	287	O
small	288	293	O
and	294	297	O
very	298	302	O
soluble	303	310	O
covalently	311	321	O
linked	322	328	O
homodimeric	329	340	O
protein	341	348	O
that	349	353	O
is	354	356	O
very	357	361	O
resistant	362	371	O
to	372	374	O
proteolytic	375	386	O
enzymes	387	394	O
and	395	398	O
to	399	401	O
pH	402	404	O
variations	405	415	O
.	415	416	O

Using	417	422	O
a	423	424	O
human	425	430	B-Organism
recombinant	431	442	O
antibody	443	451	O
(	452	453	O
scFv	453	457	O
)	457	458	O
specific	459	467	O
for	468	471	O
the	472	475	O
angiogenesis	476	488	O
marker	489	495	O
domain	496	502	O
B	503	504	O
of	505	507	O
fibronectin	508	519	B-Gene_or_gene_product
,	519	520	O
interleukin	521	532	B-Gene_or_gene_product
2	533	534	I-Gene_or_gene_product
,	534	535	O
and	536	539	O
an	540	542	O
scFv	543	547	O
able	548	552	O
to	553	555	O
neutralize	556	566	O
tumor	567	572	B-Gene_or_gene_product
necrosis	573	581	I-Gene_or_gene_product
factor	582	588	I-Gene_or_gene_product
-	588	589	I-Gene_or_gene_product
alpha	589	594	I-Gene_or_gene_product
,	594	595	O
we	596	598	O
expressed	599	608	O
various	609	616	O
biologically	617	629	O
active	630	636	O
uteroglobin	637	648	B-Gene_or_gene_product
fusion	649	655	O
proteins	656	664	O
.	664	665	O

The	666	669	O
results	670	677	O
demonstrate	678	689	O
the	690	693	O
possibility	694	705	O
to	706	708	O
generate	709	717	O
monospecific	718	730	O
divalent	731	739	O
and	740	743	O
tetravalent	744	755	O
antibodies	756	766	O
,	766	767	O
immunocytokines	768	783	O
,	783	784	O
and	785	788	O
dual	789	793	O
specificity	794	805	O
tetravalent	806	817	O
antibodies	818	828	O
.	828	829	O

Furthermore	830	841	O
,	841	842	O
compared	843	851	O
with	852	856	O
similar	857	864	O
fusion	865	871	O
proteins	872	880	O
in	881	883	O
which	884	889	O
uteroglobin	890	901	B-Gene_or_gene_product
was	902	905	O
not	906	909	O
used	910	914	O
,	914	915	O
the	916	919	O
use	920	923	O
of	924	926	O
uteroglobin	927	938	B-Gene_or_gene_product
improved	939	947	O
properties	948	958	O
of	959	961	O
solubility	962	972	O
and	973	976	O
stability	977	986	O
.	986	987	O

Indeed	988	994	O
,	994	995	O
in	996	998	O
the	999	1002	O
reported	1003	1011	O
cases	1012	1017	O
it	1018	1020	O
was	1021	1024	O
possible	1025	1033	O
to	1034	1036	O
vacuum	1037	1043	O
dry	1044	1047	O
and	1048	1051	O
reconstitute	1052	1064	O
the	1065	1068	O
proteins	1069	1077	O
without	1078	1085	O
any	1086	1089	O
aggregation	1090	1101	O
or	1102	1104	O
loss	1105	1109	O
in	1110	1112	O
protein	1113	1120	O
and	1121	1124	O
biological	1125	1135	O
activity	1136	1144	O
.	1144	1145	O

